Our data indicated that MLN4924 significantly inhibited AB's anti-tumor effects both in vitro and in vivo, underscoring the importance of the ubiquitination pathway mediated by TRIM4 and NEDD8 neddylation in TNBC progression. Here, TRIM4 is linked to neoplasm.